SUMMARY Of the 229 806 new male patients attending venereal disease clinics in England in 1976, 31.9% had recognisable non-specific genital infection (NSGI), which was easily the most common diagnostic category of the sexually transmitted diseases (STDs) and one which had increased more markedly than all the others in the previous 25 years. Many more cases of nongonococcal urethritis (NGU) are concealed under the diagnosis of gonorrhoea, as is clear from the high incidence of post-gonococcal infection following treatment with penicillin. From 44 % to 56 % of male patients with gonorrhoea can also have non-specific genital infection during the same year. A practical treatment schedule for gonorrhoea which is also effective against simultaneously acquired nongonococcal urethritis would be of great value.
Introduction
Nongonococcal urethritis (NGU) is one of the greatest problems in the management of the sexually transmitted diseases (STD) and represents a source of much psychological trauma to those affected. It is by far the most common condition requiring treatment in British clinics.
Epidemiological data RELATIVE IMPORTANCE OF THE STDS IN MEN
The relative importance of the recorded sexually transmitted diseases in men in the clinics in England is outlined in Table 1 ; the dominant role of nonspecific genital infection (NSGI) is clear. In 1976 the number of cases of NSGI in men was virtually twice that of gonorrhoea, five times that of venereal warts, 1 times that of candidosis, 16-19 times that of herpes simplex or pediculosis pubis, 25 times that of syphilis, 38-44 times that of scabies and trichomoniasis, no less than 123 times that of molluscum contagiosum, and 727 times that of chancroid, lymphogranuloma venereum, and granuloma inguinale combined.
It should be noted that the figures for NSGI now include some patients with non-specific proctitis: the vast majority of cases are, nevertheless, of nongonococcal urethritis. INCIDENCE OF NSGI In the period from 1951 to 1976, the relative increase in the incidence of NSU or NSGI in men in the clinics ( Thus with these provisions the number of male patients with gonorrhoea increased approximately 2-5 times, the number of patients treated for conditions other than urethritis increased 4-6 times, while the number of male patients with non-specific genital infections increased by at least 6-8 times.
INCIDENCE OF CONCEALED NSU
While some cases of gonorrhoea will be concealed under the diagnosis of 'other conditions requiring treatment' (for example, the relatively few men given epidemiological treatment after only one test to exclude gonorrhoea) and under the diagnosis of non-specific genital infection in clinics where cultures as well as Gram-stained smears are not routinely made on male patients, most cases of concealed gonorrhoea in men offer no great community problem as these patients have usually either been given epidemiological treatment or treated with tetracycline for nongonococcal urethritis-which treatment in practice is usually also effective against gonorrhoea. Double infections are much more important among cases of gonorrhoea, as the treatment given for gonorrhoea (for example, penicillin or ampicillin) may well be ineffective against simultaneously acquired non-specific urethritis. This is evident from the fact that high rates of post-gonococcal, nongonococcal urethritis are noted in some clinics especially after treatment with the penicillins (Table 4) .
Although some cases may be due to a persistence of inflammation with resolving gonorrhoea these are thought in the main to result from double infections. Those infections diagnosed in men are likely subsequently to be treated with tetracycline, but this treatment will not cover either non-specific infection in those who default or in those in whom the infection is subclinical or non-specific infections in female contacts of men with gonorrhoea. (Table 3) . The size of the group at highest risk by these criteria is shown in Table 5 .
The number of patients treated, with gonorrhoea and without gonorrhoea, are shown in Table 6 . The proportion of treated male patients without gonorrhoea who had NSGI are shown in Table 7 (Fig. 4); this increased from 44-3 % in 1951 to 54% in 1976. 
